These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2320706)

  • 1. Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists.
    Acquas E; Carboni E; Garau L; Di Chiara G
    Psychopharmacology (Berl); 1990; 100(4):459-63. PubMed ID: 2320706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.
    Carboni E; Acquas E; Leone P; Di Chiara G
    Psychopharmacology (Berl); 1989; 97(2):175-8. PubMed ID: 2498925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?
    Acquas E; Carboni E; Leone P; Di Chiara G
    Psychopharmacology (Berl); 1989; 99(2):151-5. PubMed ID: 2572027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats.
    Cervo L; Pozzi L; Samanin R
    Pharmacol Biochem Behav; 1996 Sep; 55(1):33-7. PubMed ID: 8870035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonists ICS 205-930 and MDL 72222.
    Corrigall WA; Coen KM
    Pharmacol Biochem Behav; 1994 Sep; 49(1):67-71. PubMed ID: 7816891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazepam-induced place preference conditioning: appetitive and antiaversive properties.
    Spyraki C; Kazandjian A; Varonos D
    Psychopharmacology (Berl); 1985; 87(2):225-32. PubMed ID: 3931151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion.
    Bienkowski P; Kuca P; Piasecki J; Kostowski W
    Alcohol; 1997; 14(1):63-9. PubMed ID: 9014026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning.
    Higgins GA; Joharchi N; Nguyen P; Sellers EM
    Psychopharmacology (Berl); 1992; 106(3):315-20. PubMed ID: 1533288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats.
    Arnold B; Allison K; Ivanová S; Paetsch PR; Paslawski T; Greenshaw AJ
    Psychopharmacology (Berl); 1995 May; 119(2):213-21. PubMed ID: 7659769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning.
    Carboni E; Acquas E; Leone P; Perezzani L; Di Chiara G
    Eur J Pharmacol; 1988 Jun; 151(1):159-60. PubMed ID: 3416924
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task.
    Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):607-11. PubMed ID: 9819806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone blockade of amphetamine place preference conditioning.
    Trujillo KA; Belluzzi JD; Stein L
    Psychopharmacology (Berl); 1991; 104(2):265-74. PubMed ID: 1876671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
    Cui R; Suemaru K; Li B; Kohnomi S; Araki H
    Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate reinforcement and naloxone aversion, as revealed by place preference paradigm, in two strains of rats.
    Dymshitz J; Lieblich I
    Psychopharmacology (Berl); 1987; 92(4):473-7. PubMed ID: 3114801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT3 receptors antagonists block morphine- and nicotine- but not amphetamine-induced place-preference conditioning.
    Acquas E; Carboni E; Leone P; Di Chiara G
    Pharmacol Res Commun; 1988 Dec; 20(12):1113-4. PubMed ID: 3212003
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists.
    Shearman GT; Tolcsvai L
    Psychopharmacology (Berl); 1987; 92(4):520-3. PubMed ID: 3114804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats.
    Rodd-Henricks ZA; McKinzie DL; Edmundson VE; Dagon CL; Murphy JM; McBride WJ; Lumeng L; Li TK
    Alcohol; 2000 May; 21(1):73-85. PubMed ID: 10946160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of drugs interacting with serotonergic 5HT3 and 5HT4 receptors on morphine place conditioning.
    Bisaga A; Sikora J; Kostowski W
    Pol J Pharmacol; 1993; 45(5-6):513-9. PubMed ID: 8012474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.